Talk about a spectacular fall from grace.
The Food and Drug Administration’s stunning order that Juul Labs must remove its vaping products from the U.S. market all but ends the meteoric rise and colossal collapse of a company that once attracted several high-profile hedge fund investors and was once the third most valuable private company.
However,
